High Antitumor Activity of RLI, an Interleukin-15 (IL-15)-IL-15 Receptor Fusion Protein, in Metastatic Melanoma and Colorectal Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0275
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2009
Authors
Publisher
American Association for Cancer Research (AACR)